News

Dept. of Health and Human Services Seeks to Limit Access to...

Dept. of Health and Human Services Seeks to Limit Access to Oral Contraception Benefits

June 6, 2017

According to recent reports, the Department of Health and Human Services (HHS) will soon seek to limit access to oral contraception benefits. “The proposed rule allowing employers to deny insurance coverage for birth control limits the application of oral contraceptives in preventive medicine, in particular, for ovarian cancer. Oral contraceptives have been shown to reduce … Continued

Advocacy

An Analysis on the Quality of Life in Long Term Survivors o...

An Analysis on the Quality of Life in Long Term Survivors of Advanced Stage Ovarian Cancer

June 1, 2017

(June 1, 2017) A study, published last month in Gynecologic Oncology, focused on an area of ovarian cancer that is rarely talked about: the quality of life (QOL) for long term survivors of advanced stage ovarian cancer. Woman surviving 8.5 years or longer, who had anywhere from 0 recurrences to multiple recurrences, were given surveys … Continued

Community

Action Alert: Protect Federal Funding for Ovarian Cancer Re...

Action Alert: Protect Federal Funding for Ovarian Cancer Research

May 27, 2017

The White House has released a proposed budget for FY2018 that makes drastic cuts to the budgets for the National Institute of Health (NIH) and Centers for Disease Control and Prevention (CDC). These cuts would reduce the NIH budget by 20% and threaten to halt breakthrough medical research advancements and delay life-saving cures. The proposed … Continued

Advocacy

The Risk of Blood Clots and Ovarian Cancer

The Risk of Blood Clots and Ovarian Cancer

May 25, 2017

(May 25, 2017) A retrospective study, published earlier this month in Obstetrics & Gynecology, looked at when women with ovarian cancer developed blood clots. One in four women diagnosed with ovarian cancer develop a blood clot, but more specifically, over eleven percent of those who developed a blood clot did so during neoadjuvant chemotherapy. Women … Continued

Research

The Positive Impact of Cognitive Behavior Therapy on Fear o...

The Positive Impact of Cognitive Behavior Therapy on Fear of Cancer Recurrence

May 22, 2017

(May 22, 2017) A recent study from the Netherlands found that a combination of cognitive behavior therapies had a positive effect on FCR, or Fear of Cancer Recurrence. Eighty-eight cancer survivors, including breast, prostate, and colorectal cancers, were divided into either a control group, which received usual care, or the therapy group. The participants that received … Continued

Research

OCRFA Funded Study Determines the Importance of Tumor Antigen

OCRFA Funded Study Determines the Importance of Tumor Antigen

May 2, 2017

(May 2, 2017) A study, published in Gynecologic Oncology, revealed the importance of tumor antigen NY-ESO-1 for ovarian cancer patients. This tumor antigen, although not normally found in healthy cells, is very prevalent in tumors such as epithelial ovarian cancers. Over the course of the 14 year study, Roswell Park tested 1,000 ovarian cancer patients … Continued

OCRA News

Cediranib and its Effect on Quality of Life

Cediranib and its Effect on Quality of Life

April 26, 2017

(April 26, 2017) A study recently published in Cancer evaluates the effect that cediranib, a drugs that stops the growth of new blood vessels, has on a patient’s quality of life (QOL) when used as maintenance therapy. Previous studies have shown that, for patients with relapsed epithelial ovarian cancer, cediranib used as maintenance therapy can … Continued

Research

OCRFA Funded Study Looks at the Link Between Hypertension a...

OCRFA Funded Study Looks at the Link Between Hypertension and Ovarian Cancer

April 25, 2017

(April 25, 2017) Researchers from Roswell Park Cancer Institute used data from 15 different studies that were part of the Ovarian Cancer Association Consortium, partially funded by OCRFA, to examine the relationship between epithelial ovarian cancer and hypertension, heart disease, diabetes, and the medications associated with those diseases. After reviewing over 7,600 cases, it was … Continued

OCRA News

OCRFA Research Finds New Genetic Variants Linked to Ovarian...

OCRFA Research Finds New Genetic Variants Linked to Ovarian Cancer

April 21, 2017

A study published in Nature Genetics has identified nine new susceptibility loci, or disease-associated alleles, for different epithelial ovarian cancer (EOC) histotypes and three susceptibility loci within BRCA1 and 2 mutation carriers with EOC. Researchers, including former OCRFA grantee and current OCRFA Scientific Advisory Committee Member Andrew Berchuck, looked at data from 25,509 EOC cases … Continued

OCRA News

The Association Between Endometriosis and Ovarian Cancer

The Association Between Endometriosis and Ovarian Cancer

April 21, 2017

(April 21, 2017) Endometriosis, a condition where the tissue that lines the inside of the uterus grows outside the uterus, has been found to be associated with an increased risk of ovarian cancer. The lives, habits, and medical histories of over 116,000 registered nurses were evaluated by the Nurses’ Health Study II for 18 years, … Continued

Research

Trends in the Receipt of Guideline Care and Survival for Wo...

Trends in the Receipt of Guideline Care and Survival for Women with Ovarian Cancer: A Population-Based Study

April 20, 2017

(April 20, 2017) Researchers from the National Cancer Institute assessed trends in the receipt of guideline care and 2-year cause-specific survival for women diagnosed with ovarian cancer. The study included 6427 women diagnosed in 2002 and in 2011. • The adjusted rate of women who received stage-appropriate surgery, 48%, was unchanged from 2002 to 2011. … Continued

Research

Random Mutations Play Major Role in Cancer

Random Mutations Play Major Role in Cancer

April 7, 2017

(April 7, 2017) A major new study published in Science claims that the reason why many people get cancer is simply just bad luck. It’s normal for people to seek a reason when someone develops cancer (did he smoke? Was it hereditary?), and certainly lifestyle factors can play a major role in the development of … Continued

Research